Use of global assessment measures in dementia drug trials

Journal of Clinical Epidemiology

Volumn 47, Issue 1, 1994, Pages 101-103

  Rockwood, Kenneth ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

CIBIC; Dementia; Outcome measures

Indexed keywords

ALZHEIMER DISEASE; CLINICAL FEATURE; DEMENTIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SHORT SURVEY;

ALZHEIMER DISEASE; CLINICAL TRIALS; HUMAN; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0028069599     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(94)90039-6     Document Type: Article

References (22)

1. A controlled trial of tacrine in Alzheimer's disease
2. Tacrine for Treating Alzheimer's Disease
3. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease
4. Treatment for Alzheimer's disease?
5. Tetrahydroaminoacradinelecithin combination treatment in patients with intermediate-stage Alzheimer's disease
6. Clinical drug trials in Alzheimer disease: What are some of the issues?
7. Antidementia drug assessment symposium
8. Scales for the assessment of Alzheimer's disease
9. Measuring functional outcomes in therapeutic trials for chronic disease
10. The brief cognitive rating scale
11. The global deterioration scale for assessment of primary degenerative dementia
12. A new clinical scale for the staging of dementia
13. The hierarchic dementia scale
14. Mild cognitive impairment in the elderly: Predictors of dementia
15. Predictive features in mild senile dementia of the Alzheimer type
16. The progression of mild idiopathic dementia in a community population
17. Rate of progression and prognostic factors in Alzheimer's disease: A prospective study
18. A feasibility study of goal attainment scaling on a geriatric service
19. Use of goal attainment scaling in measuring clinically important change in the frail elderly